Abstract
The venoms of the order Hymenoptera, comprising ants, bees, and wasps, contain numerous toxic substances including a vast array of peptides, which serve to cause cell lysis and disrupt intracellular processes. Australia has numerous indigenous species of all Hymenoptera, but the imported European honeybee (Apis mellifera) and the European wasp (Vespula germanica) have added significantly to the burden of allergic reactions expected principally from stings by members of the indigenous ant genus Myrmecia. Although Hymenoptera toxins from multiple stings may damage organs and tissues especially muscle, hepatic, and renal and disrupt coagulation, a large number of toxins are allergenic and share significant homology between species and between bees and wasps. The overwhelming clinical effects of humans are allergic reactions varying from minor local inflammation to life-threatening IgE-mediated anaphylaxis which tends to progress with repeated venom exposures. However a state of immune tolerance may be achieved by regimens of repeated exposure to small quantities of venoms or recombinant allergens (venom immunotherapy). The diagnosis, monitoring, and prediction of the immunoreactivity of individual allergic victims are major difficulties in clinical management but facilitated with wider adoption of serum tryptase measurement and new techniques of in vitro basophil activation testing.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aili SR, Touchard A, Escoubas P, et al. Diversity of peptide toxins from stinging ant venoms. Toxicon. 2014;92:166–78. https://doi.org/10.1016/j.toxicon.2014.10.021.
Anderson AN. Ant diversity in Australia: a systematic overview. In: Snelling RR, Fisher BK, Ward PS, editors. Advances in ant systematics (Hymenoptera: Formicidae): homage to E.O. Wilson – 50 years of contribution, vol. 80. Memoirs of the American Entomological Institute; 2007. p. 19–51.
Balit CR, Isbister GK, Buckley NA. Randomized controlled trial of topical aspirin in the treatment of bee and wasp stings. J Toxicol Clin Toxicol. 2003;41:801–8.
Blank S, Seismann H, McIntyre M, et al. Vitellogenins ane new high molecular weight components and allergens (Api m 12 and Ves v 6) of Apis mellifera and Vespula vulgaris venom. PLoS One. 2013;8:e62009. https://doi.org/10.1371/journal.pone.0062009.
Borer AS, Wassmann P, Schmidt M, et al. Crystal structure of sol i 2: a major allergen from fire ant venom. J Mol Biol. 2012;415:635–48. https://doi.org/10.1016/j.jmb.2011.10.009.
Boyle RJ, Elremeli M, Hockenhull J, et al. Venom immunotherapy for preventing allergic reactions to insect stings. Cochrane Database Syst Rev. 2012;10:CD008838. https://doi.org/10.1002/14651858.CD008838.pub2/full.
Bradley C. Venomous bites and stings in Australia to 2005, Injury research and statistics series, vol. 40. Adelaide: Australian Institute of Health and Welfare; 2008.
Brown SGA, Franks RW, Baldo BA, Heddle RJ. Prevalence, severity, and natural history of jack jumper ant venom allergy in Tasmania. J Allergy Clin Immunol. 2003a;111:187–92. https://doi.org/10.1067/mai.2003.48.
Brown SGA, van Eeden P, Wiese MD, et al. Causes of ant sting anaphylaxis in Australia: the Australian ant venom allergy study. Med J Aust. 2011;195:69–73.
Brown SGA, Wiese MD, Blackman KE, Heddle RJ. Ant venom immunotherapy: a double-blind, placebo-controlled, crossover trial. Lancet. 2003b;361:1001–6.
Brown SGA, Wu QX, Kelsall GRH, Heddle RJ, Baldo BA. Fatal anaphylaxis following jack jumper ant sting in southern Tasmania. Med J Aust. 2001;175:644–7.
Cavill GWK, Robertson PL, Whitfield FB. Venom and venom apparatus of the bull ant, Myrmecia gulosa (Fabr.). Science. 1964;146:79–80.
Chen L, Fadamiro HY. Re-investigation of venom chemistry of Solenopsis fire ants. II. Identification of novel alkaloids in S. invicta. Toxicon. 2009;53:479–86.
Cleland JB. Insects and their relationship to injury and disease. Man Australia Ser III Med J Aust. 1931;2:711–3.
Davies NW, Wiese MD, Brown SGA. Characterization of major peptides in ‘jack jumper’ ant venom by mass spectrometry. Toxicon. 2004;43:173–83. https://doi.org/10.1016/j.toxicon.2003.11.021.
De La Lande IS, Thomas DW, Tyler MJ. Pharmacological analysis of the venom of the ‘bulldog’ ant Myrmecia forficata. In: Raudonat HW, editor. Recent advances in the pharmacology of toxins. London: Pergamon Press; 1965.
Donovan GR, Baldo BA. Pilosulin 2 from ant venom, cloning and expression of a cDNA encoding it and its antihypertensive properties. PCT International Application 1997, p. 27. Patent No. WO 9713854.
Donovan GR, Baldo BA, Sutherland S. Molecular cloning and characterization of a major alergen (Myr p I) from the venom of the Australian jumper ant, Myrmecia pilosula. Biochim Biophys Acta. 1993;1171:272–80.
Donovan GR, Street MD, Baldo BA, Alewood D, Alewood P, Sutherland S. Identification of an IgE-binding determinant of the major allergen Myr p I from the venom of the Australian jumper ant Myrmecia pilosula. Biochim Biophys Acta. 1994;1204:48–52.
Donovan GR, Street MD, Tetaz T, et al. Expression of jumper ant (Myrmecia pilosula) venom allergens: post-translational processing of allergen gene products. Biochem Mol Biol Int. 1996;39:877–85.
Dos Santos Pinto JRA, Fox EGP, Saidemberg DM, et al. Proteomic view of the venom from the fire ant Solenopsis invicta Buren. J Proteomic Res. 2012;11:4643–53. https://doi.org/10.1021/pr300451gl.
Douglas RG, Weiner JM, Abramson MJ, O’Hehir RE. Prevalence of severe ant-venom allergy in southeastern Australia. J Allergy Clin Immunol. 1998;101:129–31.
Franca FOS, Benvenuti LA, Fan HW, et al. Severe and fatal mass attacks by “killer” bees (Africanized honey bees-Apis mellifera scutellata) in Brazil: clinicopathological studies with measurement of serum venom concentrations. Q J Med. 1994;87:269–82.
Golden DB. Discontinuing venom immunotherapy. Curr Opin Allergy Clin Immunol. 2001;1:353–6.
Golden DBK. New directions in diagnostic evaluation of insect allergy. Curr Opin Allergy Clin Immunol. 2014;14:334–9. https://doi.org/10.1097/ACI.0000000000000072.
Golden DBK, Kagey-Sobotka A, Norman PS, Hamilton RG, Lichtenstein LM. Outcomes of allergy to insect stings in children, with and without venom immunotherapy. New Eng J Med. 2004;351:668–74.
Harvey P, Sperber S, Kette F, Heddle RJ, Roberts-Thomson PJ. Bee-sting mortality in Australia. Med J Aust. 1984;140:209–11.
Hobday JD. (1998). Effective desensitisation to bee venom with monthly injections for 2 years. Australasian Society of Clinical Immunology and Allergy, 9th Annual Scientific Meeting; Brisbane; 28–31 Aug 1998.
Hoffman DR, Dove DE, Jacobson RS. Allergens in hymenoptera venom. XX. Isolation of four allergens from imported fire ant (Solenopsis invicta) venom. J Allergy Clin Immunol. 1988;82:818–27.
Hoffman DR, Sakell TH, Schmidt M. Sol I 1, the phospholipase allergen of imported fire ant venom. J Allergy Clin Immunol. 2005;115:611–6. https://doi.org/10.1016/j.jaci.2004.11.020.
Howell G, Butler J, deShazo RD, et al. Cardiodepressant and neurologic actions of Solenopsis invicta (imported fire ant) venom alkaloids. Ann Allergy Asthma Immunol. 2005;94:380–6.
Inagaki H, Akagi M, Imai HT, Taylor RW, Kubo T. Molecular cloning and biological characterization of novel antimicrobial peptides, pilosulin 3 and pilosulin 4, from a species of the Australian ant genus Myrmecia. Arch Biochem Biophys. 2004;428:170–8.
Inagaki H, Akagi M, Imai HT, et al. Pilosulin 5, a novel histamine-releasing peptide of the Australian ant, Myrmecia pilosula (Jack jumper ant). Arch Biochem Biophys. 2008;477:411–6. https://doi.org/10.1016/j.abb.2008.05.014.
King MA, Wu QX, Donovan GR, Baldo BA. Flow cytometric analysis of cell killing by the jumper ant peptide pilosulin 1. Cytometry. 1998;32:268–73.
Korenblat P, Lundie MJ, Dankner RE, Day JH. A retrospective study of epinephrine administration for anaphylaxis: how many doses are needed? Allergy Asthma Proc. 1999;20:383–6.
Krishna MT, Ewan PW, Diwaker L, et al. Diagnosis and management of hymenoptera venom allergy: British Society for Allergy and Clinical Immunology (BSACI) guidelines. Clin Exp Allergy. 2011;41:1201–20. https://doi.org/10.1111/j.1365-2222.2011.03788.x.
Levick N, Braitberg G. Massive European wasp envenomation of a child. Emerg Med. 1996;8:239–45.
Lewis JC, Day AJ, De la Lande IS. Phospholipase A in the venom of the Australian bulldog ant Myrmecia pyriformis. Toxicon. 1968;6:109–12.
Lewis JC, De La Lande IS. Pharmacologieal and enzymatic constituents of the venom of an Australian ‘bull dog’ ant Myrmecia pyriformis. Toxicon. 1967;4:225–34.
Li R, Zhang L, Fang Y, et al. Proteome and phosphoproteome analysis of honeybee (Apis mellifera) venom collected from electrical stimulation and manual extraction of the venom gland. BMC Genomics. 2013;14:766.
Lockwood SA, HaghiPour-Peasley J, Hoffman DR, Deslippe RJ. Identification, expression, and immune-reactivity of Sol I 2 & Sol I 4 proteins of queen red imported fire ants, Solenopsis invicta Buren (Hymenoptera: Formicidae). Toxicon. 2012;60:752–9. https://doi.org/10.1016/j.toxicon.2012.05.011.
MacGlashan DW. Basophil activation testing. J Allergy Clin Immunol. 2013;132:777–87. https://doi.org/10.1016/j.jaci.2013.06.038.
Matuszek MA, Hodgson WC, King RG, Sutherland SK. Some enzymatic activities of two Australian ant venoms: a jumper ant Myrmecia pilosula and a bulldog ant Myrmecia pyriformis. Toxicon. 1994;32:1543–9.
Matuszek MA, Hodgson WC, Sutherland SK, King RG. Pharmacological studies of jumper ant (Myrmecia pilosula) venom: evidence foe the presence of histamine, and haemolytic and eicosanoid-releaseing factors. Toxicon. 1992;30:1081–91.
Matysiak J, Hajduk J, Pietrzak L, Schmelzer CEH, Kokot ZJ. Shotgun proteome analysis of honeybee venom using targeted enrichment strategies. Toxicon. 2014;90:255–64. https://doi.org/10.1016/j.toxicon.2014.08.069.
McGain F, Harrison J, Winkel KD. Wasp sting mortality in Australia. Med J Aust. 2000;173:198–200.
McGain F, Winkel KD. Ant sting mortality in Australia. Toxicon. 2002;40:1095–100.
Mitra A. Function of the Dufour’s gland in solitary and social hymenoptera. J Hymenopt Res. 2013;35:33–58. https://doi.org/10.3897/JHR.35.4783.
Moreau SJM, Asgari S. Venom proteins from parasitoid wasps and their biological functions. Toxins. 2015;7:2385–412. https://doi.org/10.3390/toxins7072385.
Moreno M, Girault E. Three valuable peptides from be and wasp venoms for therapeutic and biotechnological use: melittin, apamin and mastoparan. Toxins. 2015;7:1126–50. https://doi.org/10.3390/toxins7041126.
Müller UR. Bee venom allergy in beekeepers and their family members. Curr Opin Allergy Clin Immunol. 2005;5:343–7.
Padavattan S, Schmidt M, Hoffman DR, Marković-Housley Z. Crystal structure of the major allergen from fire ant venom, Sol i 3. J Mol Biol. 2008;383:178–85. https://doi.org/10.1016/j.jmb.2008.08.023.
Prahlow JA, Barnard JJ. Fatal anaphylaxis to fire ant stings. Am J Forensic Med Pathol. 1998;19:137–42.
Pursley RE. Stinging Hymenoptera. Am Bee J. 1973;113:131–2.
Simons FE, Roberts JR, Gu X, Simons KJ. Epinephrine absorption in children with a history of anaphylaxis. J Allergy Clin Immunol. 1998;101:33–7.
Solley GO, Vanderwoude C, Knight GK. Anaphylaxis due to red imported fire ant sting. Med J Aust. 2002;176:521–3.
Street MD, Donovan GR, Baldo BA. Molecular cloning and characterization of the major allergen Myr p II from the venom of the jumper ant Myrmecia pilosula: Myr p I and Myr p II share a common protein leader sequence. Biochem Biophys Acta. 1996;1305:87–97.
Touchard A, Aili SR, Fox EGP, et al. The biochemical toxin arsenal from ant venoms. Toxins. 2016;8:1.
Van Vaerenbergh M, Debyser G, Devreese B, de Graaf DC. Exploring the hidden honeybee (Apis mellifera) venom proteome by integrating a combinatorial peptide ligand library approach with FTMS. J Proteome. 2014;99:169–78. https://doi.org/10.1016/jprot.2013.04.039.
Visscher PK, Vetter RS, Camazine S. Removing bee stings. Lancet. 1996;348:301–2.
Wanandy T, Gueven N, Davis NW, Brown SGA, Wiese MD. Pilosulins: a review of the structure and mode of action of venom from an Australian ant Myrmecia pilosula. Toxicon. 2015;98:54–61. https://doi.org/10.1016/j.toxicon.2015.02.013.
Wanstall JC, De La Lande IS. Fractionation of bulldog ant venom. Toxicon. 1974;12:649–55.
Welton RE, Williams DJ, Liew D. Injury trends from envenoming in Australia, 2000–2013. Intern Med J. 2017;47:170–6. https://doi.org/10.1111/imj.13297.
Wiese MD, Brown SGA, Chataway TK, et al. Myrmecia pilosula (Jack jumper) ant venom: identification of allergens and revised nomenclature. Allergy. 2007;62:437–43. https://doi.org/10.1111/j.1398-9995.2007.01320.x.
Wiese MD, Chataway TK, Davies NW, et al. Proteomic analysis of Myrmecia pilosula (jack jumper) ant venom. Toxicon. 2006;47:2018–7.
Wiese MD, Milne RW, Davies NW, Chataway TK, Brown SGA, Heddle RJ. Myrmecia pilosula (Jack jumper) ant venom: validation of a procedure to standardize an allergy vaccine. J Pharm Biomed Anal. 2008;46:58–65. https://doi.org/10.1016/j.jpba.2007.08.028.
Winkel KD, Bordeaux S, Harrison J, Levick NR. European wasps: an emerging health hazard in Australia. 4th International Hymenopterists Conference, Canberra, Jan 1991; 1999.
Wu QX, King MA, Donovan GR, et al. Cytotoxicity of pilosulin 1, a peptide from the venom of the jumper ant Myrmecia pilosula. Biochim Biophys Acta. 1998;1425:74–80.
Xuan BH, Mai HL, Thi TX, Nguyen HN, Rabenou RA. Swarming hornet attacks: shock and acute kidney injury – a large case series from Vietnam. Nephrol Dial Transplant. 2010;25:1146–50.
Zelezetsky I, Pag U, Antcheva N, Sahl HG, Tossi A. Identification abd optimization of an antimicrobial peptide from the ant venom toxin pilosulin. Arch Biochem Biophys. 2005;434:358–64. http://www.bbcm.univ.trieste.it/-tossi/antimic.html
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Science+Business Media B.V., part of Springer Nature
About this entry
Cite this entry
Tibballs, J. (2018). Envenomation by Australian Hymenoptera: Ants, Bees, and Wasps. In: Vogel, CW., Seifert, S., Tambourgi, D. (eds) Clinical Toxinology in Australia, Europe, and Americas. Toxinology. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-7438-3_69
Download citation
DOI: https://doi.org/10.1007/978-94-017-7438-3_69
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-017-7436-9
Online ISBN: 978-94-017-7438-3
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences